San Diego’s Iambic Therapeutics releases AI platform for better outcome predictions

Iambic’s AI-driven Enchant™ platform predicts clinical outcomes better than industry standard—from the discovery stage of drug development. Utilizing early discovery data to make key pharmacokinetic (PK) predictions, the model helps assess drug candidate viability to reduce development costs.